##gff-version 3
##sequence-region Q5VT25 1 1732
Q5VT25	UniProtKB	Chain	1	1732	.	.	.	ID=PRO_0000086392;Note=Serine/threonine-protein kinase MRCK alpha	
Q5VT25	UniProtKB	Domain	77	343	.	.	.	Note=Protein kinase;Ontology_term=ECO:0000255,ECO:0000269;evidence=ECO:0000255|PROSITE-ProRule:PRU00159,ECO:0000269|PubMed:9092543;Dbxref=PMID:9092543	
Q5VT25	UniProtKB	Domain	344	414	.	.	.	Note=AGC-kinase C-terminal	
Q5VT25	UniProtKB	Domain	1082	1201	.	.	.	Note=PH;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00145	
Q5VT25	UniProtKB	Domain	1227	1499	.	.	.	Note=CNH;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00795	
Q5VT25	UniProtKB	Domain	1571	1584	.	.	.	Note=CRIB;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00057	
Q5VT25	UniProtKB	Nucleotide binding	83	91	.	.	.	Note=ATP;Ontology_term=ECO:0000250,ECO:0000255;evidence=ECO:0000250|UniProtKB:P54265,ECO:0000255|PROSITE-ProRule:PRU00159	
Q5VT25	UniProtKB	Zinc finger	1012	1062	.	.	.	Note=Phorbol-ester/DAG-type;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00226	
Q5VT25	UniProtKB	Coiled coil	437	820	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q5VT25	UniProtKB	Coiled coil	880	943	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q5VT25	UniProtKB	Active site	201	201	.	.	.	Note=Proton acceptor;Ontology_term=ECO:0000250,ECO:0000255,ECO:0000255;evidence=ECO:0000250|UniProtKB:P54265,ECO:0000255|PROSITE-ProRule:PRU00159,ECO:0000255|PROSITE-ProRule:PRU10027	
Q5VT25	UniProtKB	Binding site	106	106	.	.	.	Note=ATP;Ontology_term=ECO:0000255,ECO:0000269;evidence=ECO:0000255|PROSITE-ProRule:PRU00159,ECO:0000269|PubMed:11283256;Dbxref=PMID:11283256	
Q5VT25	UniProtKB	Modified residue	222	222	.	.	.	Note=Phosphoserine%3B by autocatalysis;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11283256;Dbxref=PMID:11283256	
Q5VT25	UniProtKB	Modified residue	234	234	.	.	.	Note=Phosphoserine%3B by autocatalysis;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11283256;Dbxref=PMID:11283256	
Q5VT25	UniProtKB	Modified residue	240	240	.	.	.	Note=Phosphothreonine%3B by autocatalysis;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11283256;Dbxref=PMID:11283256	
Q5VT25	UniProtKB	Modified residue	1127	1127	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:O54874	
Q5VT25	UniProtKB	Modified residue	1545	1545	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q5VT25	UniProtKB	Modified residue	1611	1611	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q5VT25	UniProtKB	Modified residue	1613	1613	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q5VT25	UniProtKB	Modified residue	1629	1629	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q5VT25	UniProtKB	Modified residue	1651	1651	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:21406692,PMID:23186163	
Q5VT25	UniProtKB	Modified residue	1664	1664	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q5VT25	UniProtKB	Modified residue	1669	1669	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q5VT25	UniProtKB	Modified residue	1693	1693	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q5VT25	UniProtKB	Modified residue	1719	1719	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q5VT25	UniProtKB	Modified residue	1721	1721	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:23186163	
Q5VT25	UniProtKB	Alternative sequence	550	630	.	.	.	ID=VSP_051859;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15723050;Dbxref=PMID:15723050	
Q5VT25	UniProtKB	Alternative sequence	969	1009	.	.	.	ID=VSP_051862;Note=In isoform 4. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:16710414,ECO:0000303|Ref.2;Dbxref=PMID:16710414	
Q5VT25	UniProtKB	Alternative sequence	969	981	.	.	.	ID=VSP_051860;Note=In isoform 3%2C isoform 5 and isoform 6. Missing;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:15723050,ECO:0000303|PubMed:9455484;Dbxref=PMID:15723050,PMID:9455484	
Q5VT25	UniProtKB	Alternative sequence	969	969	.	.	.	ID=VSP_051861;Note=In isoform 2. R->TDPVENTYVWNPSVKFHIQSRST;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:17974005;Dbxref=PMID:17974005	
Q5VT25	UniProtKB	Alternative sequence	973	981	.	.	.	ID=VSP_051863;Note=In isoform 2. CTPASKGRR->TSSEAEPVK;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:17974005;Dbxref=PMID:17974005	
Q5VT25	UniProtKB	Alternative sequence	1597	1597	.	.	.	ID=VSP_035286;Note=In isoform 6. M->MPGFPYPSPHHHSGLISSPINFEHIYHMTVNSAEKFLSPDSINPEYSPSLRSVPGTPSFMTLR;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:9455484;Dbxref=PMID:9455484	
Q5VT25	UniProtKB	Natural variant	50	50	.	.	.	ID=VAR_040830;Note=In a lung neuroendocrine carcinoma sample%3B somatic mutation. E->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=PMID:17344846	
Q5VT25	UniProtKB	Natural variant	231	231	.	.	.	ID=VAR_040831;Note=T->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=dbSNP:rs34614709,PMID:17344846	
Q5VT25	UniProtKB	Natural variant	537	537	.	.	.	ID=VAR_040832;Note=I->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=dbSNP:rs56364976,PMID:17344846	
Q5VT25	UniProtKB	Natural variant	780	780	.	.	.	ID=VAR_045583;Note=T->M;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=dbSNP:rs56119119,PMID:17344846	
Q5VT25	UniProtKB	Natural variant	790	790	.	.	.	ID=VAR_045584;Note=Y->C;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=dbSNP:rs34943764,PMID:17344846	
Q5VT25	UniProtKB	Natural variant	1148	1148	.	.	.	ID=VAR_045585;Note=A->T;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=dbSNP:rs56219089,PMID:17344846	
Q5VT25	UniProtKB	Natural variant	1211	1211	.	.	.	ID=VAR_045586;Note=R->H;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=dbSNP:rs961490,PMID:17344846	
Q5VT25	UniProtKB	Natural variant	1317	1317	.	.	.	ID=VAR_045587;Note=V->I;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17344846,ECO:0000269|PubMed:17974005;Dbxref=dbSNP:rs1929860,PMID:17344846,PMID:17974005	
Q5VT25	UniProtKB	Natural variant	1418	1418	.	.	.	ID=VAR_040833;Note=I->K;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=PMID:17344846	
Q5VT25	UniProtKB	Natural variant	1469	1469	.	.	.	ID=VAR_045588;Note=A->V;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=dbSNP:rs55687355,PMID:17344846	
Q5VT25	UniProtKB	Natural variant	1618	1618	.	.	.	ID=VAR_045589;Note=T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17344846;Dbxref=dbSNP:rs2297417,PMID:17344846	
Q5VT25	UniProtKB	Natural variant	1699	1699	.	.	.	ID=VAR_045590;Note=A->V;Dbxref=dbSNP:rs2802269	
Q5VT25	UniProtKB	Natural variant	1712	1712	.	.	.	ID=VAR_057104;Note=A->V;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:17974005,ECO:0000269|PubMed:9455484,ECO:0000269|Ref.2;Dbxref=dbSNP:rs2802269,PMID:17974005,PMID:9455484	
Q5VT25	UniProtKB	Mutagenesis	106	106	.	.	.	Note=Loss of kinase activity. K->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11283256;Dbxref=PMID:11283256	
Q5VT25	UniProtKB	Mutagenesis	222	222	.	.	.	Note=Increase in autophosphorylation but not kinase activity. S->L;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11283256;Dbxref=PMID:11283256	
Q5VT25	UniProtKB	Mutagenesis	234	234	.	.	.	Note=Loss of autophosphorylation and kinase activity. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11283256;Dbxref=PMID:11283256	
Q5VT25	UniProtKB	Mutagenesis	240	240	.	.	.	Note=Loss of autophosphorylation and kinase activity. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11283256;Dbxref=PMID:11283256	
Q5VT25	UniProtKB	Mutagenesis	403	403	.	.	.	Note=Loss of autophosphorylation and kinase activity. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11283256;Dbxref=PMID:11283256	
Q5VT25	UniProtKB	Mutagenesis	1579	1579	.	.	.	Note=Loss of CDC42 binding%3B when associated with A-1582. H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9418861;Dbxref=PMID:9418861	
Q5VT25	UniProtKB	Mutagenesis	1582	1582	.	.	.	Note=Loss of CDC42 binding%3B when associated with A-1579. H->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:9418861;Dbxref=PMID:9418861	
Q5VT25	UniProtKB	Sequence conflict	25	25	.	.	.	Note=C->Y;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q5VT25	UniProtKB	Sequence conflict	809	809	.	.	.	Note=D->N;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q5VT25	UniProtKB	Sequence conflict	1521	1521	.	.	.	Note=L->V;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q5VT25	UniProtKB	Sequence conflict	1688	1688	.	.	.	Note=G->K;Ontology_term=ECO:0000305;evidence=ECO:0000305	
